trimethoprim--sulfamethoxazole-drug-combination has been researched along with Hemangioma* in 2 studies
2 other study(ies) available for trimethoprim--sulfamethoxazole-drug-combination and Hemangioma
| Article | Year |
|---|---|
[Pneumocystis jiroveci pneumonia during prolonged corticosteroid therapy in an immunocompetent infant].
Pneumocystis jiroveci (PJ) infection is rare in infants and is suggestive of primary or secondary immunodeficiency. We report on a case of severe PJ pneumonia in an immunocompetent infant after prolonged corticosteroid treatment.. A 5 1/2 month-old girl presented with hypoxemic respiratory distress. Her medical record was remarkable only for a bulky parotid haemangioma, which was treated with prolonged oral corticosteroid therapy. The chest X-ray showed a mixed alveolar-interstitial pattern, and bronchoalveolar lavage revealed the presence of PJ. A favourable outcome was obtained after three weeks of intravenous trimethoprim-sulfamethoxazole treatment.. PJ infection should be suspected in infants presenting with progressive respiratory distress associated with a mixed alveolar-interstitial pattern. Its potential seriousness justifies prophylactic therapy during prolonged immunosuppressive treatment (chemotherapy, corticosteroid treatment). Topics: Administration, Oral; Anti-Infective Agents; Anti-Inflammatory Agents; Betamethasone; Bronchoalveolar Lavage; Female; Glucocorticoids; Hemangioma; Humans; Infant; Parotid Neoplasms; Pneumocystis carinii; Pneumonia, Pneumocystis; Radiography, Thoracic; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
Pneumocystis carinii pneumonia in a 3-month-old infant receiving high-dose corticosteroid therapy for airway hemangiomas.
Primary infection with Pneumocystis carinii usually occurs early in life, and young infants receiving prolonged treatment with high-dose corticosteroids may be at risk for the development of symptomatic disease. Prophylaxis with trimethoprim-sulfamethoxazole is safe and effective and should be considered for such infants, particularly those with underlying airway abnormalities. We describe a 3-month-old immunocompetent infant who developed severe P carinii pneumonia after 6 weeks of high-dose corticosteroid therapy for cervicofacial and airway hemangiomas. Topics: Anti-Infective Agents; Female; Glucocorticoids; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Pneumonia, Pneumocystis; Prednisolone; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |